£187.20 – £337.50Price range: £187.20 through £337.50
This TB500 + BPC157 peptide blend contains 10 mg of TB-500 and 10 mg of BPC-157, providing a multi-pathway research tool for controlled studies involving actin-regulation dynamics, angiogenic signaling, and cellular-repair pathways. TB-500, a synthetic fragment of Thymosin Beta-4, is used to investigate cytoskeletal remodeling and cell-migration behavior. BPC-157 is frequently studied for its influence on vascular signaling and tissue-protection responses in regulated laboratory environments.


Researchers value this dual-peptide design because it allows parallel investigation of two cellular-repair pathways: TB-500-linked actin regulation and BPC-157-associated angiogenic signaling. The TB500 + BPC157 peptide blend supports studies assessing how cytoskeletal remodeling, tissue protection responses, and recovery-linked cellular communication may interact under controlled experimental conditions.
Typical research applications include:
Studying actin-linked cell migration and cytoskeletal behavior
Mapping angiogenic and microvascular signaling in vitro or ex vivo
Investigating peptide-driven tissue-repair mechanisms
Comparing combined exposure to single-compound controls
Both components demonstrate clear and reproducible performance in regulated laboratory systems, supporting structured mechanistic research and measurable outcomes. This formulation is well suited to experiments requiring precision dosing and traceable input materials.
This product is supplied strictly as a high-purity laboratory reagent for scientific research only. It is not approved for human or veterinary administration, therapeutic use, diagnostic procedures, or clinical application. Handling must comply with institutional safety protocols and all relevant regulations.
For research use only. Not for human consumption.
Discount Applied Successfully!
Your savings have been added to the cart.